- Home
- » Tags
- » Hydroxychloroquine
Top View
- Chloroquine and Hydroxychloroquine: Efficacy in the Treatment of the COVID-19
- Treatment of Q Fever Endocarditis: Comparison of 2 Regimens
- Hydroxychloroquine (All Populations Monograph)
- Hydroxychloroquine and Chloroquine: a Potential and Controversial Treatment for COVID‑19
- Guidelines for Treatment of Malaria in the United States 1 (Based on Drugs Currently Available for Use in the United States — October 1, 2019)
- QUANTITY LIMIT PRIOR AUTHORIZATION CRITERIA BRAND NAME (Generic) (Chloroquine)
- COVID-19 Treatment Guidelines Clinical Management No Specific Treatment for COVID-19 Is Currently Available
- Common Study Protocol for Observational Database Studies WP5 – Analytic Database Studies
- COMPARISON of the WHO ATC CLASSIFICATION & Ephmra/Intellus Worldwide ANATOMICAL CLASSIFICATION
- PATIENT FACT SHEET Hydroxychloroquine
- Hydroxychloroquine
- Guidelines for Treatment of Malaria in the United States (Based on Drugs
- A Potential Ethical Dilemma for Rheumatologists During the COVID-19 Pandemic
- Drugs for Parasitic Infections (2013 Edition)
- Chloroquine and Hydroxychloroquine Fact Sheet
- Doxycycline Is a Safe Alternative to Hydroxychloroquine + Azithromycin
- Approaches to Soft Drug Analogues of Dihydrofolate Reductase Inhibitors
- Medicines for the Prevention of Malaria While Traveling Hydroxychloroquine (Plaquenil™)
- [Product Monograph Template
- Chemoprophylaxis of COVID-19 with Hydroxychloroquine - a Study of Health Care Workers Attitude, Adherence to Regime and Side Effects
- Plaquenil ® Hydroxychloroquine Sulfate Tablets, USP
- Anti-Malarial Medications for Chemoprophylaxis
- Download (Accessed on 27 June 2020)
- COVID-19: Chloroquine and Hydroxychloroquine Research
- Frequently Asked Questions on the Emergency Use Authorization (EUA) for Chloroquine Phosphate and Hydroxychloroquine Sulfate
- Hydroxychloroquine and the Burden of Proof
- DARAPRIM® (Pyrimethamine)
- COVID-19: Implications for People with Chagas Disease
- Hydroxychloroquine for the Treatment of Hidradenitis Suppurativa
- Chloroquine and Chloroquinoline Derivatives As Models for the Design of Modulators of Amyloid Peptide Precursor Metabolism
- Hydroxychloroquine, a Less Toxic Derivative of Chloroquine, Is
- WHO Model List of Essential Medicines
- Customs and Border Protection Medication Formulary
- COVID-19: Chloroquine and Hydroxychloroquine Research
- Letter of Authorization
- COVID-19: Implications for People with Chagas Disease
- Guidelines for ATC Classification and DDD Assignment 2021
- The Safety of Elective Surgery with Concurrent Use of Immunosuppressants Katelyn Koons1, Victoria Plotas1, David S
- In Vitro Antiviral Activity of Doxycycline Against SARS-Cov-2
- Hydroxychloroquine/Chloroquine Safety During Off-Label Use For
- Hydroxychloroquine Sulfate
- Plaquenil Data Sheet
- HYDROXYCHLOROQUINE (Plaquenil), and CHLOROQUINE INFORMATION
- Molecular Docking of Quinine, Chloroquine and Hydroxychloroquine to Angiotensin Converting Enzyme 2 (ACE2) Receptor for Discovering New Potential COVID-19 Antidote
- Plaquenil® Hydroxychloroquine Sulfate, Usp
- Understanding Plaquenil in the Treatment of Lupus
- Guidelines for ATC Classification and DDD Assignment 2013
- COMPARISON of the WHO ATC CLASSIFICATION & Ephmra/PBIRG ANATOMICAL CLASSIFICATION
- ORIGINAL ARTICLES Comparison of Viral Clearance Between Ivermectin
- Medicines for the Prevention of Malaria While Traveling Hydroxychloroquine (Plaquenil™)
- The Use of Antimalarial Drugs Against Viral Infection
- Antimalarial Therapy – (P0101)
- Methotrexate an Old Drug with New Tricks
- Quinine Inhibits Infection of Human Cell Lines with SARS-Cov-2
- Cutaneous Lupus Erythematosus (CLE) with Or Without Associated Systemic Lupus Erythematosus
- Medications That Can Cause Peripheral Neuropathy
- CHAPTER E26 Pharmacology of Agents Used to Treat Parasitic Infections